Review ArticleProceedings of the 2016 Santa Fe Bone Symposium: New Concepts in the Management of Osteoporosis and Metabolic Bone Diseases
Key Words
Cited by (0)
Conflicts of interest: E. Michael Lewiecki, MD, Research Grant: Amgen, Lilly, Merck; Consultant: Amgen, Lilly, Merck, Radius, Alexion, Shire, AbbVie. John P. Bilezikian, MD, Research Grant: Shire; Consultant: Amgen, Shire, Radius. Susan V. Bukata, MD, Consultant: Merck, Amgen, Lilly. Pauline Camacho, MD, Research Grant: Amgen, Lilly; Consultant: Amgen. Bart L. Clarke, MD, Research Grant: Shire. Michael R. McClung, MD, Consultant: Amgen, Merck, Radius. Paul D. Miller, MD, Research Grants: Amgen, Alexion, Merck, Merck Serrano, Boehringer Ingelheim, Novartis, Novo Nordisk, Immunodiagnostics, Roche Diagnostics, Takeda, National Bone Health Alliance; Consultant: Amgen, Lilly, Merck, Alexion, AgNovos, Radius, Roche; Speaker: Alexion, Amgen, Radius. John Shepherd, PhD, Nothing to disclose.